Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
- Enrico Maffini*
- , Maud Ngoya
- , Jacques Emmanuel Galimard
- , Samia Harbi
- , Nicolaus Kröger
- , Uwe Platzbecker
- , Henrik Sengeloev
- , Charles Craddock
- , Victoria Potter
- , Goda Choi
- , Patrice Chevallier
- , Friedrich Stölzel
- , Eleni Tholouli
- , Johan Maertens
- , Fabio Ciceri
- , Jan Cornelissen
- , Jaime Sanz
- , Alexandros Spyridonidis
- , Francesco Lanza
- , Arnon Nagler
*Corresponding author for this work
- S. Orsola-Malpighi Hospital
- Hôpital Saint-Antoine
- Institut Paoli Calmettes
- University Medical Center Hamburg-Eppendorf
- University Hospital Leipzig
- Rigshospitalet
- Birmingham Centre for Cellular Therapy and Transplantation
- King’s College Hospital
- University Medical Centre Groningen
- CHU de Nantes
- Technische Universität Dresden
- Manchester Royal Infirmary
- University Hospitals Leuven
- IRCCS Ospedale San Raffaele
- Hospital Universitario La Fe
- University of Patras
- Romagna Transplant Network
- Tel Aviv University
Research output: Contribution to journal › Article › Academic › peer-review
18
Citations
(Scopus)